Search company, investor...

Founded Year



Series B | Alive

Total Raised


Last Raised

$10.61M | 2 mos ago

About Tilak Healthcare

Tilak Healthcare specializes in digital healthcare. It develops medically-prescribed video games for the monitoring and follow-up of patients suffering from chronic diseases. The company's application targets ophthalmology with macular diseases, which affect a large number of patients in the aging populations of developed countries. It was founded in 2016 and is based in Paris, France.

Headquarters Location

74 Rue du Faubourg Saint-Antoine

Paris, 75012,


+ 33 (0) 185732702



Research containing Tilak Healthcare

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Tilak Healthcare in 2 CB Insights research briefs, most recently on Jan 24, 2023.

Expert Collections containing Tilak Healthcare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tilak Healthcare is included in 3 Expert Collections, including Conference Exhibitors.


Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare


Digital Health

10,714 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Digital Health 50

50 items

Tilak Healthcare Patents

Tilak Healthcare has filed 3 patents.

The 3 most popular patent topics include:

  • diseases of the eye and adnexa
  • disorders of choroid and retina
  • ophthalmology
patents chart

Application Date

Grant Date


Related Topics




Graphical user interface elements, Graphical user interfaces, Graphical control elements, Graphical user interface testing, User interfaces


Application Date


Grant Date



Related Topics

Graphical user interface elements, Graphical user interfaces, Graphical control elements, Graphical user interface testing, User interfaces



Latest Tilak Healthcare News

Tilak Healthcare’s €10 Million Funding Round

Oct 20, 2023

Bird & Bird represented Tilak Healthcare in the transaction, and Reed Smith and Jones Day represented the investors. Tilak Healthcare announced it has raised has raised €10 million […]

Tilak Healthcare Frequently Asked Questions (FAQ)

  • When was Tilak Healthcare founded?

    Tilak Healthcare was founded in 2016.

  • Where is Tilak Healthcare's headquarters?

    Tilak Healthcare's headquarters is located at 74 Rue du Faubourg Saint-Antoine, Paris.

  • What is Tilak Healthcare's latest funding round?

    Tilak Healthcare's latest funding round is Series B.

  • How much did Tilak Healthcare raise?

    Tilak Healthcare raised a total of $21.51M.

  • Who are the investors of Tilak Healthcare?

    Investors of Tilak Healthcare include iBionext, SWEN Capital Partners, Elaia Partners, Matmut, Adelie and 7 more.

  • Who are Tilak Healthcare's competitors?

    Competitors of Tilak Healthcare include OKKO Health.


Compare Tilak Healthcare to Competitors

OKKO Health Logo
OKKO Health

OKKO Health provides personalized smartphone software for remote monitoring of visual health. It develops biomarkers for the eye to track eye movements with smart devices. It offers visual acuity detection, home monitoring of eye health, clinical dashboard and analytics, and more. It primarily caters to the healthcare industry. The company was founded in 2018 and is based in Bristol, United Kingdom.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.